OneMedNet Corporation

OneMedNet Corporation

ONMD
OneMedNet CorporationUS flagNASDAQ Global Market
0.68
USD
-0.01
- -
38.72MMarket Cap
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.2
0.27
0.29
0.14
0.02
0.03
0.03
Basic EPS, GAAP
-0.7
-0.73
-7.55
-4.65
-0.36
-0.06
-0.07
Free Cash Flow per Basic Share
-0.53
-0.46
-1.18
-0.66
-0.25
-0.17
-0.15
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-5.55
-6.28
-14.3
-12.58
-3.62
-2.34
-2.21
Tangible Book Value per Share
-0.71
-1.41
-10.91
-1.85
-0.57
-0.07
-0.08
Basic Weighted Avg Shares
4
4
4
7
28
45
48
Sales/Revenue/Turnover
1
1
1
1
1
1
1
Operating Margin (%)
-355.83
-248.27
-1,369.3
-671.2
-1,493.78
-711.33
-752.99
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-3
-3
-30
-34
-10
-3
-3
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-342.41
-269.37
-2,641.02
-3,308.52
-1,575.27
-206.11
-254.13
Working Capital
-1
-4
-26
-13
-16
-3
-4
LT Debt
2
2
2
- -
- -
- -
- -
Total Equity
-3
-6
-26
-13
-16
-3
-4
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
3.39
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
- -
1
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
50
52
53
Market Capitalization
45
45
41

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
1
2
1
Cash, Cash Equivalents & STI
1
1
- -
Accounts Receivable, Net
1
- -
1
Inventories
- -
- -
- -
Total Current Liabilities
5
5
5
Payables & Accruals
4
3
4
ST Debt
- -
- -
1
Deferred Revenue
1
- -
1

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
69.98%
-81.41%
Free Cash Flow
- -
39.19%
7.33%
Net Income, GAAP
- -
161.65%
-72.35%
Sales/Revenue/Turnover
- -
20.2%
111.35%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
1
2025
- -
- -
- -
1
1
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.08
-0.14
-0.07
- -
-0.36
2025
-0.06
0.08
-0.01
- -
-0.06
2026
-0.04
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Aaron Green
Full Time Employees
23
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Address
6385 Old Shady Oak Road Eden Prairie MN United States of America 55344
IPO Date
Jun 24, 2021
Business
OneMedNet Corporation OneMedNet Corporation (Nasdaq: ONMD), a healthcare software company, provides AI-powered real-world data (RWD) solutions, including digital medical image management, exchange, sharing, and de-identification platforms, primarily through its proprietary iRWD platform and BEAM medical imaging exchange system. The iRWD platform delivers regulatory-grade, de-identified imaging and clinical data, encompassing electronic health records, laboratory results, and longitudinal patient records across domains such as oncology, cardiology, rare diseases, and beyond; it supports pharmaceutical companies, medical device manufacturers, contract research organizations, AI developers, and academic researchers with secure, federated access to data from over 1,750 healthcare sites without transferring patient information from provider servers. BEAM facilitates imaging exchange among hospitals, healthcare systems, imaging centers, physicians, and patients, while recent expansions include AI-driven data masking services for de-identifying sensitive information in healthcare, finance, retail, and telecom sectors to enable compliant AI training and testing. Founded in 2006 and headquartered in Eden Prairie, Minnesota, the company operates in the Americas, Europe, and the Middle East, targeting life sciences, AI, and healthcare innovation markets with a workforce of approximately 23 employees. Its federated network model ensures data privacy and HIPAA compliance, positioning it in the competitive real-world evidence and health information services industry. Recent developments include a strategic partnership in August 2025 with one of the world's five largest medical device companies under a master services agreement for AI-powered RWD services, encompassing four purchase orders for medical imaging data; a collaboration with Palantir Technologies announced in October 2025 to advance AI-driven healthcare data integration and analytics; and an alliance with mlHealth360 in October 2025 to provide RWD for AI model development in healthcare. Additional 2025 initiatives encompass partnerships with Protege for real-time multimodal patient data access, Datavant’s real-world data ecosystem, Inka Health for cancer therapy trial external control arms, Medcase for healthcare data annotation market entry, and integrations with Amazon Data Exchange and Bayer Data Marketplace; the company expanded its cardiovascular data network by 85 centers, grew its clinical exam repository to over 121 million, and raised approximately $3.7 million through private placements. These moves enhance its subscription-based live data access model, annual recurring revenue, and capabilities in AI innovation and post-market surveillance.

Company News

APIChatGPT
  • OneMedNet Executes on Growth Strategy: Secures Over $3 Million in New Bookings, Surpassing Full-Year 2025

  • OneMedNet Surpasses 90 Million Patient Journeys and 270 Million Studies within its Network

  • Insider Buying: OneMedNet (NASDAQ:ONMD) Director Acquires $249,999.22 in Stock

  • OneMedNet Goes Live with 80 Million Patient Journeys and Billions of Records

  • OneMedNet Announces Strong 2025 Financials and Advances AI-Driven iRWD™ powered by Palantir Foundry enabling Conversational Search on Real-Time Medical Data

  • OneMedNet, Onco-Innovations and Inka Health Announces Collaboration Aimed to Accelerate Potential for Oncology Drug Development Using Real-World Data and AI

  • OneMedNet and Navidence Announce Strategic Collaboration: Empowering Pharma with Precision Real-World Data Insights

  • What's Going On With Penny Stock OneMedNet On Tuesday?

  • OneMedNet Announces Next Phase of Commercial Launch with its Real-World Data (RWD) Platform powered by Palantir Foundry

  • OneMedNet Partners with ViuHealth to Enhance Autoimmune Dataset Scale, Accelerating Recurring Revenue from Life Sciences and AI Customers

  • OneMedNet Announces Strategic Neuro Data Partnership with Risorius to Advance EEG-Based Digital Biomarkers

  • OneMedNet (NASDAQ:ONMD) vs. Rapid7 (NASDAQ:RPD) Head-To-Head Survey

  • OneMedNet Reports Record 2025 Bookings of $2.79 Million, Surpassing Prior Year by More Than 4.1X and Accelerating Subscription Transition

  • AI Medical Imaging Revolution: Software-Native Tech Disrupts $45B Market

  • OneMedNet Real-World Data Supports FDA 510(k) Clearance of AI-Powered Scaida BrainCT-ICH Software

  • OneMedNet Delivers a Real-World Data feed of 1.5M Patients consisting of 4M encounters

  • Head-To-Head Analysis: OneMedNet (NASDAQ:ONMD) vs. CI&T (NYSE:CINT)

  • OneMedNet CEO Aaron Green Issues Letter to Shareholders Highlighting 2025

  • OneMedNet Reports Strong Momentum and Industry Excitement at RSNA

  • OneMedNet to Showcase Transformative New Platform at RSNA 2025